Study of SAF312 as an Eye Drop for Treatment of Eye Pain Following Photorefractive Keratectomy (PRK) Surgery
Status:
Completed
Trial end date:
2018-02-21
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if SAF312 eye drops have an adequate safety and
efficacy profile to justify further clinical development for the treatment of ocular pain
associated with corneal epithelial defect such as after photorefractive keratectomy (PRK)
surgery